Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

403
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
403
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

267
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
267
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

319
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
319
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

384
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
384
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.0K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

845
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
845

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transjugular renal biopsy in a case of nephrotic syndrome with extrahepatic portal venous obstruction.

Indian journal of nephrology·2013
Same author

Measurement of associated production of vector bosons and top quark-antiquark pairs in pp collisions at sqrt[s]=7  TeV.

Physical review letters·2013
Same author

The cost of materials for intra-arterial thrombectomy.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences·2013
Same author

Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs.

Physical review letters·2013
Same author

No evidence of drug-induced pancreatitis in rats treated with exenatide for 13 weeks.

Diabetes, obesity & metabolism·2012
Same author

Guidelines and recommendations for studies on psychosocial aspects of patients with craniofacial anomalies.

Mymensingh medical journal : MMJ·2012

Related Experiment Video

Updated: Jan 23, 2026

Microsurgical Creation of Giant Bifurcation Aneurysms in Rabbits for the Evaluation of Endovascular Devices
07:21

Microsurgical Creation of Giant Bifurcation Aneurysms in Rabbits for the Evaluation of Endovascular Devices

Published on: September 8, 2023

1.0K

Aneurysm recurrence after endovascular treatment.

D Roy1

  • 1CHUM Notre-Dame Hospital, 1560 Sherbrooke east, Simard Z12909, Montreal, Canada H2L4M1. daniel.roy.chum@ssss.gouv.qc.ca

Neuro-Chirurgie
|April 3, 2012
PubMed
Summary

Aneurysm recurrence after endovascular treatment poses risks, prompting extensive follow-up and technological advancements. Understanding these risks is crucial for patient care and treatment development.

Area of Science:

  • Vascular Surgery
  • Interventional Radiology
  • Neurosurgery

Background:

  • Endovascular treatment for aneurysms carries a risk of recurrence.
  • The precise risk of hemorrhage from aneurysm recurrence post-treatment is not well-established.
  • Concerns regarding recurrence significantly influence patient management and technological innovation.

Purpose of the Study:

  • To review current literature on aneurysm recurrence after endovascular treatment.
  • To discuss the implications of aneurysm recurrence on patient follow-up and treatment strategies.
  • To explore the impact of recurrence concerns on the development of new endovascular technologies.

Main Methods:

  • Literature review of studies on endovascular aneurysm treatment and recurrence.

More Related Videos

Simulator Training for Endovascular Neurosurgery
08:08

Simulator Training for Endovascular Neurosurgery

Published on: May 6, 2020

4.1K
A New Murine Model of Endovascular Aortic Aneurysm Repair
08:51

A New Murine Model of Endovascular Aortic Aneurysm Repair

Published on: July 7, 2013

14.8K

Related Experiment Videos

Last Updated: Jan 23, 2026

Microsurgical Creation of Giant Bifurcation Aneurysms in Rabbits for the Evaluation of Endovascular Devices
07:21

Microsurgical Creation of Giant Bifurcation Aneurysms in Rabbits for the Evaluation of Endovascular Devices

Published on: September 8, 2023

1.0K
Simulator Training for Endovascular Neurosurgery
08:08

Simulator Training for Endovascular Neurosurgery

Published on: May 6, 2020

4.1K
A New Murine Model of Endovascular Aortic Aneurysm Repair
08:51

A New Murine Model of Endovascular Aortic Aneurysm Repair

Published on: July 7, 2013

14.8K
  • Analysis of data regarding hemorrhage risk associated with aneurysm recurrence.
  • Discussion of technological advancements aimed at reducing recurrence rates.
  • Main Results:

    • Established literature on hemorrhage risk post-aneurysm recurrence is limited.
    • Concerns about recurrence necessitate intensive imaging surveillance and potential re-interventions.
    • Technological progress seeks to minimize recurrence but may introduce new complications.

    Conclusions:

    • Further research is needed to accurately quantify hemorrhage risk from aneurysm recurrence.
    • Balancing the risks of recurrence with the complications of treatment and follow-up is essential.
    • Ongoing technological development should prioritize both efficacy in preventing recurrence and patient safety.